myLaminin Perspectives

Learn how ICH E6 (R3) is reshaping clinical trials through risk-based quality management, decentralized research oversight, data integrity, and continuous inspection readiness across global clinical research operations.

Multi-site clinical trials are widely used across North America to improve recruitment and accelerate timelines, but hidden operational risks often undermine success. Site variability, uneven engagement, communication breakdowns, and fragmented technology adoption create systemic inefficiencies that erode data quality and compliance. Without integrated oversight and standardized processes, complexity scales faster than control, increasing trial failure risk.